出诊信息
注：出诊时间如有变化，以当日挂号为准| 门诊时间 | 门诊地点 |
|---|---|
| 星期 一 (下午) | 庆春院区 |
个人简介
浙江大学医学院附属第一医院副主任医师
专业擅长
擅长急慢性白血病，恶性淋巴瘤，多发性骨髓瘤，骨髓增生异常综合征等恶性血液病的诊治及血小板减少和各类贫血的诊治。
研究方向
急性白血病的发病机制及新疗法
成果奖项：（近五年主要成果及奖励情况）
成果奖项：（近五年主要成果及奖励情况）
1, Lou Y,Shao L,Mao L,Lu Y,Ma Y,Fan C,Jiang H,Li J,Jin J*.Efficacy and predictive factors of venetoclax combined with azacitidine as salvage therapy in advanced acute myeloid leukemia patients: A multicenter retrospective study. Leuk Res.2020 Feb 14;91:106317.
2,Mei C, Ren Y, Zhou X, Ye L, Ma L, Luo Y, Lin P, Xu W, Lu C, Yang H, Yu W,Mao L, Wei J, Jin J, Tong H*.Clinical and biological characteristics of acute myeloid leukemia with 20-29% blasts: a retrospective single-center study. Leuk Lymphoma. 2019 May;60(5):1136-1145.
3, Yu W, Guo Q, Wang Z, Mao L, Wei J, Jin J*, Wang J*, Clinical Significance of Prognostic Nutritional Index for Patients with Diffuse Large B-cell Lymphoma, Nutr Cancer, 2018: 1-6.doi: 10.1080/01635581.2018.1540718.
4, Li Y, Yang C, Mao L, Wang J, Li C, Qian W*, Clinical characteristics of angioimmunoblastic T-cell lymphoma in China and C-reactive protein as an independent prognostic factor, Medicine (Baltimore), 2017, 96(39): e8091
5, Wang J#, Guo Q#, Ma ZX, Ma QL, Yu MX, Yin XF, Lu SS, Xie HQ, Jiang YH, Shen D, Ma LY, Shi H, Yu WJ, Lou YJ, Li Y, Yang M, Xu GX, Mao L, Li JH, Wang HP, Wang DM, Wei JY*, Tong HY*, Huang J*, Jin J*, Impact of Chemotherapy Delay on Overall Survival for AML with IDH1/2 Mutations: A Study in Adult Chinese Patients, PLoS One, 2015, 10(10): e0140622
6.国家自然科学基金面上项目，81470305，D/L-2-HG两种对映异构体在AML患者的预后意义及降低高水平2-HG的机制研究，2015/01-2018/12，70万元，已结题，参与。
